Growing Investment in Neurodegenerative Disease Research
The Parkinson’s disease drug market is entering a phase of steady transformation as pharmaceutical innovation, demographic shifts, and expanding diagnosis rates reshape the treatment landscape. Parkinson’s disease (PD) is a progressive neurodegenerative disorder that primarily affects movement, creating a long-term need for pharmacological therapy to manage symptoms and improve...
0 Commentaires 0 Parts 81 Vue 0 Aperçu
Commandité